@article{2f92c2ccbf1745dfa8feba94171d4784,
title = "The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment",
abstract = "Patients with Zollinger-Ellison syndrome (ZES) are treated by proton pump inhibitors (PPIs) to protect them from severe and potentially lethal peptic complications related to massive gastric acid hypersecretion. We report here on the dangerous consequences of interrupting PPI therapy.",
keywords = "Esophageal Stenosis, Humans, Intestinal Perforation, Male, Middle Aged, Proton Pump Inhibitors, Withholding Treatment, Zollinger-Ellison Syndrome",
author = "Pierre Poitras and Marie-H{\'e}l{\`e}ne Gingras and Rehfeld, {Jens F}",
note = "Copyright {\textcopyright} 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.cgh.2011.08.012",
language = "English",
volume = "10",
pages = "199--202",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B./Saunders Co",
number = "2",
}